So Far – So Good...

You appear to meet the pre-screening requirements for the Low Back study! However, only the research study staff can fully determine if you qualify to enroll in the study. Please enter your information below and a study representative will contact you soon.

Sorry, you are not eligible at this time...

Thank you so much for your interest in the Low Back study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

A Research Study For Lumbar Disc Herniation

Testing a One-Time Investigational Treatment for Low Back & Leg Pain.

See if you can take part! Answer a few Questions and Get your Pre-qualify Results Right away.

Question 1 of 4

Are you between 30-70 years of age?

Question 2 of 4

Do you suffer from shooting leg pain, numbness or tingling?

Question 3 of 4

In which leg are you experiencing pain?

Question 4 of 4

Do you have lower back pain that could be due to lumbar disc herniation?

Would you rather talk to someone on the phone instead? Call: 1.877.835.4154

Why Should I Participate?

The study drug might help the discomfort associated with lumbar disc herniation. Previous studies with the study drug showed a possible benefit in some patients. A beneficial effect cannot, however, be guaranteed, and you may not receive any direct personal benefits from being in this study. You will be given close attention from the study staff during the time you are involved in the study. You may receive information about your health from physical examinations and medical tests done in this study.

Your participation in this study may benefit the community, scientists, and doctors by providing increased knowledge and information about the treatment of lumbar disc herniation.

Study related tests and procedures are provided at no cost, and no insurance is needed. Reimbursement for study-related expenses and compensation for completed visits may be available. You are free to leave the study at any time. If you leave the study before it is finished, there will be no penalty to you.

Header Image

About the Study

The purpose of this study is to evaluate the effectiveness (how well the study drug works) and long-term safety of the study drug in people with a lumbar disc herniation.

Throughout the study you will have various tests and examinations done and will be asked questions about your overall quality of life, pain level of your leg and lower back, recent medications, injuries, and illnesses. In some circumstances, repeat tests and/or examinations (including laboratory, X-ray, and/or MRI tests) may be necessary.

How might the study drug work?

The study drug treatment is a possible method by which the soft central portion of the herniated lumbar intervertebral disc is broken down or dissolved. As a result, the disc herniation may be reduced, and leg pain, lower back pain, and/or numbness may be improved.

Header Image

About Clinical Research

What is a clinical trial?

A clinical trial is a research study designed to evaluate health outcomes. Some clinical trials determine the safety and effectiveness of investigational drugs or ways of using known therapies for new potential medical treatments. Other clinical trials assess health outcomes in human populations within their routine medical care. This study is evaluating an investigational drug to find out if it is safe and effective in treating leg pain in those with lumbar disc herniation.

Why are they done?

Without clinical trials most common medications that we use every day would not be available. Additionally, some people do not get the results that they need from their current medical treatment, requiring scientists and clinical researchers to work to find better ways to provide new and improved therapies.

Before a drug can be approved for use in humans, a thorough process of research must be done. Clinical trials are one of the key steps in the research process before a new drug can be approved for use in a general population.